Plaksha: Ayurvedic Use, Evidence & Safety

TL;DR

Plaksha is a fig tree of Ayurveda (Ficus tsiela, in the F. lacor–*virens* complex) whose bark is the main medicinal part. Classical texts list it for urinary restraint, bleeding disorders, and wound care: traditional uses, not proof. Modern studies are animal-only: antidiabetic and antiarthritic effects in rats. No human trials exist, and safety data are limited.

What it is

Plaksha is a large fig tree of the Moraceae family. The Charak Samhita Research, Training and Skill Development Centre's herb database identifies it botanically as Ficus tsiela Roxb., with the Sanskrit synonyms Plaksha and Parkati (Plaksha: Charak Samhita Research Centre, 2023). A note on identity: other Ayurvedic and botanical sources map "plaksha" to closely related figs: Ficus lacor Buch.-Ham., Ficus virens Aiton, and Ficus infectoria, which are treated as a synonym complex in much of the literature, so studies published under those names are attributed to the same traditional drug, though the taxonomy is contested and the identification remains provisional. The stem bark is the principal part used; leaves, leaf buds, and fruit are also employed (Plaksha: Charak Samhita Research Centre, 2023).

Traditional use

In Charak Samhita, plaksha appears in the mutrasangrahaniya mahakashaya (the group of ten drugs that restrain excessive urination, Sutra sthana 4/9) and the kashaya-skandha (astringent group, Vimana sthana 8/144), and as an ingredient in formulations including Chandanadhya taila and Chandanadhya ghrita, in parisechana (therapeutic pouring) for bleeding piles (rakta arsha), and as a dietary article (pathya) (Plaksha: Charak Samhita Research Centre, 2023). Its Ayurvedic pharmacology is recorded as: astringent taste (kashaya rasa), cold potency (sheeta virya), pungent post-digestive effect (katu vipaka), heavy and dry qualities (guru, ruksha guna), pacifying kapha and pitta (Plaksha: Charak Samhita Research Centre, 2023). All of these are traditional uses, not clinical proof.

What modern research says

Antidiabetic activity (animal study)

Fruit and cork extracts of Ficus lacor were evaluated in streptozotocin-induced diabetic Wistar rats over 21 days at 200 and 400 mg/kg against glibenclamide, with glucose, insulin, glycosylated hemoglobin, lipid profile, and renal/hepatic markers measured (Mule & Naikwade, J Appl Pharm Sci 2022). The extracts showed antidiabetic potential in this rat model. Animal diabetes models frequently fail to translate to humans, and no human study of plaksha for blood sugar exists.

Antiarthritic activity (animal study)

Aerial-root extracts of Ficus lacor were tested in adjuvant-induced arthritis in rats against indomethacin, reducing arthritic lesions in a dose-dependent manner comparable to the standard drug (reviewed in Int J Herbal Med 2020; Ficus pharmacology review). Again: rats, not people.

Hepatoprotective and other preclinical findings

An ethanolic bark extract of Ficus lacor reduced serum SGPT, SGOT, and bilirubin in carbon-tetrachloride-induced liver injury in albino rats (Tripathi et al. 2007, reviewed in Int J Herbal Med 2020). Reviews also catalogue in-vitro anti-inflammatory, antibacterial, and antioxidant findings for F. virens bark and leaf extracts. The honest summary: the entire modern evidence base for plaksha is preclinical. There are no human trials for any indication, and traditional claims about bleeding, wounds, or urinary disorders remain untested clinically.

Safety & contraindications

No human safety studies of plaksha were found, and no adverse effects are documented in the reviewed sources: absence of data, not evidence of safety. Traditional use includes both external application (bark powder on wounds, decoction gargles) and internal use (bark decoctions), but the safety of internal medicinal doses has not been studied in humans. Anyone considering plaksha preparations, especially if pregnant, breastfeeding, managing a bleeding disorder, or on medication, should consult a qualified practitioner. Per the hard rule on dosage (only with pharmacopoeial or clinical-trial citation), no dosage section is included: no pharmacopoeial or trial dose was found.

FAQs

What exactly is plaksha?

An Ayurvedic fig tree. The Charak Samhita Research Centre identifies it as Ficus tsiela Roxb. (synonyms Plaksha, Parkati). Much of the literature uses the names Ficus lacor, Ficus virens, or Ficus infectoria for the same traditional drug (Plaksha: Charak Samhita Research Centre, 2023). The stem bark is the main medicinal part.

What is plaksha traditionally used for?

Restraining excessive urination (it heads a classical group of ten such drugs), bleeding disorders, wound and ulcer care, mouth ulcers, and as an ingredient in medicated oils and ghees (Plaksha: Charak Samhita Research Centre, 2023). Its profile, astringent, cooling, kapha-pitta pacifying, matches these uses. Traditional, not clinically proven.

Is there any human evidence for plaksha?

None. The modern literature is entirely preclinical: antidiabetic effects of fruit and cork extracts in diabetic rats, antiarthritic effects of aerial-root extracts in arthritic rats, and hepatoprotective effects of bark extract in rats with chemically induced liver injury (Mule & Naikwade 2022; Int J Herbal Med 2020). No human trials exist for any indication.

Can plaksha help with diabetes or bleeding?

Not on the basis of evidence. The antidiabetic findings are from rat studies, and the bleeding/wound uses are traditional only. Using it to manage blood sugar or a bleeding disorder without medical supervision would be unsafe.

Is plaksha safe?

Unknown in any rigorous sense: no human safety studies exist. Traditional use spans external wound application to internal bark decoctions, but medicinal internal doses have no safety data. Consult a qualified practitioner, especially in pregnancy, breastfeeding, or with bleeding disorders or medication use.

Sources

Disclaimer

This article is for educational purposes only and is not medical advice. Herbal products can interact with medications and are not suitable for everyone. Talk to a qualified healthcare practitioner before use — especially if you are pregnant, breastfeeding, managing a medical condition, or taking prescription medicines.